FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and concerns an anhydrous antimicrobial composition containing an effective amount of an antimicrobial agent containing carageenan, which represent lambda carageenan in an amount of approximately 50% dry weight of carageenan, wherein the rest of said carageenan is other than at least one lambda carageenan, as well as a physiologically acceptable metal salt and an antiretroviral agent specified in a group consisting of non-nucleoside reverse transcriptase inhibitors and nucleoside reverse transcriptase inhibitors.
EFFECT: invention provides the complete blockage of vaginal infection progression over the period of 24 hours.
21 cl, 11 dwg, 1 tbl, 20 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED MEDICINAL PREPARATION FOR PREVENTION OF SEXUALLY TRANSMITTED INFECTIONS | 2015 |
|
RU2697051C2 |
| MICROBICIDAL DENDRIMER COMPOSITION DELIVERY SYSTEM | 2006 |
|
RU2396962C2 |
| COMPOSITIONS AND METHODS FOR INHIBITING INFLAMMATION AND DISEASES USING ALGINIC ACID-BASED ANTIMICROBIAL COMPOUND | 2014 |
|
RU2691950C1 |
| ANTIVIRAL AGENT AGAINST HERPES SIMPLEX VIRUS TYPE 1 | 2022 |
|
RU2782935C1 |
| DERIVATIVES OF BENZAMIDE, PHARMACEUTICAL COMPOSITION, HALENIC PREPARATION FOR ORAL ADMINISTRATION, OINTMENT FOR TREATMENT OF ABDOMINAL CAVITY LOWER SECTION DISEASES, MIXTURE OF COMPOUNDS, FOOD COMPOSITION | 1995 |
|
RU2140915C1 |
| METHODS AND COMPOSITIONS FOR PREVENTING TRANSMISSION OF HIV INFECTION | 2011 |
|
RU2594249C2 |
| COMPOSITION COMPRISING LOW-MOLECULAR FRAGMENTS OF PEPTIDOGLICANE OF GRAM-NEGATIVE BACTERIA FOR PREVENTING OR TREATING OF HUMAN DISEASES | 2009 |
|
RU2441906C2 |
| COMPOSITION BASED ON NANOPARTICLES WITH IMPROVED PENETRATION THROUGH MUCOUS MEMBRANES | 2013 |
|
RU2598627C2 |
| NEW SALT OF TENOFOVIR DISOPROXIL | 2015 |
|
RU2660438C1 |
| NARROW POLY-AND MONO-DISPERSED WATER-SOLUBLE OLIGOMER, METHOD OF PREPARING THEREOF, PHARMACEUTICAL AGENT AND METHOD OF INHIBITING ACTIVITY OF VIRUSES | 1993 |
|
RU2160746C2 |
